Predictive value of <scp>post‐treatment C‐reactive protein‐to‐albumin</scp> ratio in locally advanced <scp>non–small</scp> cell lung cancer patients receiving durvalumab after chemoradiotherapy-Reference-Cited by-同舟云学术

Predictive value of post‐treatment C‐reactive protein‐to‐albumin ratio in locally advanced non–small cell lung cancer patients receiving durvalumab after chemoradiotherapy

Published:2022-05-26 Issue:14 Volume:13 Page:2031-2040
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Araki Taisuke¹^ORCID,Tateishi Kazunari¹^ORCID,Komatsu Masamichi¹,Sonehara Kei¹^ORCID,Wasamoto Satoshi²,Koyama Shigeru³,Yoshiike Fumiaki⁴,Hama Mineyuki⁵,Nishie Kenichi⁶,Kondo Daichi⁷,Agatsuma Toshihiko⁸,Kato Akane⁹,Takata Munetake¹⁰,Kanda Shintaro¹¹^ORCID,Hanaoka Masayuki¹,Koizumi Tomonobu¹¹^ORCID

Affiliation:

1. First Department of Internal Medicine Shinshu University School of Medicine Matsumoto Japan

2. Department of Respiratory Medicine Saku Central Hospital Advanced Care Center Saku Japan

3. Department of Respiratory Medicine Japanese Red Cross Society Nagano Hospital Nagano Japan

4. Department of Respiratory Medicine Nagano Municipal Hospital Nagano Japan

5. Department of Respiratory Medicine Japanese Red Cross Society Suwa Hospital Suwa Japan

6. Department of Respiratory Medicine Iida Municipal Hospital Iida Japan

7. Department of Respiratory Medicine Hokushin General Hospital Nakano Japan

8. Department of Respiratory Medicine Shinshu Ueda Medical Center Ueda Japan

9. Department of Respiratory Medicine Ina Central Hospital Ina Japan

10. Department of Respiratory Medicine Jiseikai Aizawa Hospital Matsumoto Japan

11. Department of Hematology and Medical Oncology Shinshu University School of Medicine Matsumoto Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14484

Reference37 articles.

1. Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

2. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

3. A retrospective analysis of delays in the diagnosis of lung cancer and associated costs

4. Improved Survival Associated with Neoadjuvant Chemoradiation in Patients with Clinical Stage IIIA(N2) Non–Small-Cell Lung Cancer

5. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pneumonitis Risk After Chemoradiotherapy With and Without Immunotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis;International Journal of Radiation Oncology*Biology*Physics;2024-07

2. Effect of Sequence of Radiotherapy Combined With Immunotherapy on the Incidence of Pneumonitis in Patients With Lung Cancer: A Systematic Review and Network Meta-Analysis;Clinical Lung Cancer;2024-01

3. Chemoradiotherapy Combined with Immunotherapy in Stage III Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Efficacy and Safety Outcomes;Oncology;2023-10-30

4. Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis;eClinicalMedicine;2023-10

5. Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy: A Multicenter Retrospective Study;Cancers;2023-09-01